Morgan Stanley’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Sell
292,567
-207,594
-42% -$936K ﹤0.01% 4963
2025
Q1
$2.22M Buy
500,161
+179,354
+56% +$795K ﹤0.01% 4539
2024
Q4
$2.51M Buy
320,807
+72,085
+29% +$564K ﹤0.01% 4549
2024
Q3
$3.27M Buy
248,722
+45,582
+22% +$599K ﹤0.01% 4296
2024
Q2
$2.45M Buy
203,140
+15,043
+8% +$182K ﹤0.01% 4421
2024
Q1
$3.06M Sell
188,097
-302,193
-62% -$4.91M ﹤0.01% 4305
2023
Q4
$3.34M Buy
490,290
+382,416
+355% +$2.61M ﹤0.01% 4642
2023
Q3
$588K Sell
107,874
-22,748
-17% -$124K ﹤0.01% 5098
2023
Q2
$887K Sell
130,622
-119,827
-48% -$814K ﹤0.01% 4901
2023
Q1
$1.25M Sell
250,449
-43,514
-15% -$218K ﹤0.01% 4731
2022
Q4
$1.43M Buy
293,963
+38,471
+15% +$188K ﹤0.01% 4665
2022
Q3
$3.68M Sell
255,492
-118,664
-32% -$1.71M ﹤0.01% 3944
2022
Q2
$5.66M Sell
374,156
-167,405
-31% -$2.53M ﹤0.01% 3653
2022
Q1
$6.43M Buy
541,561
+251,177
+86% +$2.98M ﹤0.01% 3403
2021
Q4
$4.71M Buy
290,384
+206,378
+246% +$3.34M ﹤0.01% 3783
2021
Q3
$2.4M Sell
84,006
-8,160
-9% -$233K ﹤0.01% 4415
2021
Q2
$3.11M Sell
92,166
-122,270
-57% -$4.13M ﹤0.01% 4251
2021
Q1
$6.48M Buy
214,436
+82,151
+62% +$2.48M ﹤0.01% 3139
2020
Q4
$6.55M Buy
132,285
+56,893
+75% +$2.82M ﹤0.01% 2970
2020
Q3
$2.89M Sell
75,392
-6,559
-8% -$252K ﹤0.01% 3296
2020
Q2
$3.54M Buy
81,951
+76,700
+1,461% +$3.31M ﹤0.01% 3029
2020
Q1
$137K Sell
5,251
-241,850
-98% -$6.31M ﹤0.01% 5049
2019
Q4
$7.72M Buy
247,101
+116,105
+89% +$3.63M ﹤0.01% 2703
2019
Q3
$3.41M Buy
130,996
+130,718
+47,021% +$3.41M ﹤0.01% 3294
2019
Q2
$6K Sell
278
-1,104
-80% -$23.8K ﹤0.01% 6282
2019
Q1
$37K Sell
1,382
-9,584
-87% -$257K ﹤0.01% 5801
2018
Q4
$223K Buy
10,966
+10,866
+10,866% +$221K ﹤0.01% 5235
2018
Q3
$3K Buy
+100
New +$3K ﹤0.01% 6525